Cody, everything you say is accurate, but there ar
Post# of 36515
Second is the numbers. The number of countries impacted. The number of deaths. The number of cases. The number of hospital beds. The number of ICU wards at or near capacity. If NGIO works diligently, it will have an opportunity to make an impact. Much of the data EvH has compiled over the past 20 years may be proprietary and only available to Generex.
It is a long shot, but do we (as investors) truly know what we have in Ii-key? I am interested in finding out. If, and it's a big if, NGIO is busy working on a multi-virus platform and/or treatment and mitigation, we may just have something at the end of the road. We're waiting to see those river cards.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)